{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["active ingredient", "bioavailability", "herbal medicine", "medicinal plants", "nanotechnology", "obesity", "prodrug", "traditional Chinese medicine (TCM)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36263142", "DateRevised": {"Year": "2022", "Month": "10", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "03"}], "Language": ["eng"], "ELocationID": ["1016004", "10.3389/fphar.2022.1016004"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Chinese medicinal herbs as potential prodrugs for obesity.", "Pagination": {"StartPage": "1016004", "MedlinePgn": "1016004"}, "Abstract": {"AbstractText": ["Obesity is a leading worldwide health threat with ever-growing prevalence, it promotes the incidence of various diseases, particularly cardiovascular disease, metabolic syndrome, diabetes, hypertension, and certain cancers. Traditional Chinese Medicine (TCM) has been used to control body weight and treat obesity for thousands of years, Chinese medicinal herbs provide a rich natural source of effective agents against obesity. However, some problems such as complex active ingredients, poor quality control, and unclear therapeutic mechanisms still need to be investigated and resolved. Prodrugs provide a path forward to overcome TCM deficiencies such as absorption, distribution, metabolism, excretion (ADME) properties, and toxicity. This article aimed to review the possible prodrugs from various medicinal plants that demonstrate beneficial effects on obesity and seek to offer insights on prodrug design as well as a solution to the global obesity issues."], "CopyrightInformation": "Copyright \u00a9 2022 Law, Wang, Lu, Au, Chow, Leung and Xu."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Law", "ForeName": "Siu Kan", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, Hong Kong SAR, China."}], "LastName": "Wang", "ForeName": "Yanping", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Lu", "ForeName": "Xinchen", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Au", "ForeName": "Dawn Ching Tung", "Initials": "DCT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Chow", "ForeName": "Wesley Yeuk Lung", "Initials": "WYL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong SAR, China."}], "LastName": "Leung", "ForeName": "Albert Wing Nang", "Initials": "AWN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China."}], "LastName": "Xu", "ForeName": "Chuanshan", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abet V., Filace F., Recio J., Alvarez-Builla J., Burgos C. (2017). Prodrug approach: An overview of recent cases. Eur. J. Med. Chem. 127, 810\u2013827. 10.1016/j.ejmech.2016.10.061", "ArticleIdList": ["10.1016/j.ejmech.2016.10.061", "27823878"]}, {"Citation": "Ahmed H. H., Kotob S. E., Abd-Rabou A. A., Aglan H. A., Elmegeed G. A., Mohawed O. A. (2021). Pre-clinical evidence for the anti-obesity potential of quercetin and curcumin loaded chitosan/PEG blended PLGA nanoparticles. Biomed. Pharmacol. J. 14 (4), 1731\u20131759. 10.13005/bpj/2274", "ArticleIdList": ["10.13005/bpj/2274"]}, {"Citation": "Ahmed M., Gaffen S. L. (2010). IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 21 (6), 449\u2013453. 10.1016/j.cytogfr.2010.10.005", "ArticleIdList": ["10.1016/j.cytogfr.2010.10.005", "PMC3259710", "21084215"]}, {"Citation": "Albert A. (1958). Chemical aspects of selective toxicity. Nature 182, 421\u2013422. 10.1038/182421a0", "ArticleIdList": ["10.1038/182421a0", "13577867"]}, {"Citation": "Azlan A., Sultana S., Huei C. S., Razman M. R. (2022). Antioxidant, anti-obesity, nutritional and other beneficial effects of different chili pepper: A review. Molecules 27 (3), 898. 10.3390/molecules27030898", "ArticleIdList": ["10.3390/molecules27030898", "PMC8839052", "35164163"]}, {"Citation": "Bahadori E., Farjami Z., Rezayi M., Lngari H., Darroudi M., Avan A., et al. (2019). Recent advances in nanotechnology for the treatment of metabolic syndrome. Diabetes Metab. Syndr. 13 (2), 1561\u20131568. 10.1016/j.dsx.2019.03.002", "ArticleIdList": ["10.1016/j.dsx.2019.03.002", "31336522"]}, {"Citation": "\nBastard J-P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., et al.  (2006). Recent advances in the relationship among obesity, inflammation, and insulin resistance. Eur. Cytokine Netw.\n17, 4\u201312. https://www.jle.com/fr/index.phtml\n", "ArticleIdList": ["16613757"]}, {"Citation": "Bode L. M., Bunzel D., Huch M., Cho G. S., Ruhland D., Bunzel M., et al. (2013). In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am. J. Clin. Nutr. 2, 295\u2013309. 10.3945/ajcn.112.049379", "ArticleIdList": ["10.3945/ajcn.112.049379", "23283496"]}, {"Citation": "Bradford P. G. (2013). Curcumin and obesity. BioFactors 39, 78\u201387. 10.1002/BIOF.1074", "ArticleIdList": ["10.1002/BIOF.1074", "23339049"]}, {"Citation": "Cao Y., Liu J., Huang C., Tao Y., Wang Y., Chen X., et al. (2022). Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization. J. Pharmacol. Sci. 148 (1), 116\u2013124. 10.1016/j.jphs.2021.10.005", "ArticleIdList": ["10.1016/j.jphs.2021.10.005", "34924115"]}, {"Citation": "Chen J. W., Kong Z. L., Tsai M. L., Lo C. Y., Ho C. T., Lai C. S. (2018). Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. J. Food Drug Anal. 26 (3), 1075\u20131085. 10.1016/j.jfda.2018.01.005", "ArticleIdList": ["10.1016/j.jfda.2018.01.005", "PMC9303024", "29976400"]}, {"Citation": "Cheung C. H. Y., Law S. K. (2022). Could \"celastrol\" Be suitable for the treatment of obesity? Regen. Med. Ther. 5 (1), 55\u201356. 10.36959/654/394", "ArticleIdList": ["10.36959/654/394"]}, {"Citation": "Cho S., Yoon Y. R. (2018). Understanding the pharmacokinetics of prodrug and metabolite. Transl. Clin. Pharmacol. 26 (1), 1\u20135. 10.12793/tcp.2018.26.1.1", "ArticleIdList": ["10.12793/tcp.2018.26.1.1", "PMC6989223", "32055540"]}, {"Citation": "Cho S. H., Lee J. S., Thabane L., Lee J. (2009). Acupuncture for obesity: Asystematic review and meta-analysis. Int. J. Obes. 33, 183\u2013196. 10.1038/ijo.2008.269", "ArticleIdList": ["10.1038/ijo.2008.269", "19139756"]}, {"Citation": "Choi B. H., Ahn I. S., Kim Y. H., Park J. W., Lee S. Y., Hyun C. K., et al. (2006). Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp. Mol. Med. 3138 (6), 599\u2013605. 10.1038/emm.2006.71", "ArticleIdList": ["10.1038/emm.2006.71", "17202835"]}, {"Citation": "Chu X., Sun B., Huang Q., Peng S., Zhou Y., Zhang Y. (2020). Quantitative knowledge presentation models of traditional Chinese medicine (TCM): A review. Artif. Intell. Med. 103, 101810. 10.1016/j.artmed.2020.101810", "ArticleIdList": ["10.1016/j.artmed.2020.101810", "32143806"]}, {"Citation": "Chung M. C., Ferreira E. I., Santos J. L., Giarolla J., Rando D. G., Almeida A. E., et al. (2007). Prodrugs for the treatment of neglected diseases. Molecules 13 (3), 616\u2013677. 10.3390/molecules13030616", "ArticleIdList": ["10.3390/molecules13030616", "PMC6245083", "18463559"]}, {"Citation": "Davis C. D. (2016). The gut microbiome and its role in obesity. Nutr. Today 51 (4), 167\u2013174. 10.1097/NT.0000000000000167", "ArticleIdList": ["10.1097/NT.0000000000000167", "PMC5082693", "27795585"]}, {"Citation": "Di Naso F. C., Porto R. R., Fillmann H. S., Maggioni L., Padoin A. V., Ramos R. J., et al. (2015). Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obes. (Silver Spring) 23 (1), 120\u2013129. 10.1002/oby.20919", "ArticleIdList": ["10.1002/oby.20919", "25292174"]}, {"Citation": "Du Y., Giannangelo C., He W., Shami G. J., Zhou W., Yang T., et al. (2022). Dimeric artesunate glycerophosphocholine conjugate nano-assemblies as slow-release antimalarials to overcome kelch 13 mutant artemisinin resistance. Antimicrob. Agents Chemother. 66 (5), e0206521. 10.1128/aac.02065-21", "ArticleIdList": ["10.1128/aac.02065-21", "PMC9112877", "35416709"]}, {"Citation": "Fan W., Huang Y., Zheng H., Li S., Li Z., Yuan L., et al. (2020). Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms. Biomed. Pharmacother. 132, 110915. 10.1016/j.biopha.2020.110915", "ArticleIdList": ["10.1016/j.biopha.2020.110915", "33254433"]}, {"Citation": "Fu L., Niu X., Jin R., Xu F., Ding J., Zhang L., et al. (2020). Triptonide inhibits metastasis potential of thyroid cancer cells via astrocyte elevated gene-1. Transl. Cancer Res. 9 (2), 1195\u20131204. 10.21037/tcr.2019.12.94", "ArticleIdList": ["10.21037/tcr.2019.12.94", "PMC8799231", "35117464"]}, {"Citation": "Fulton S., D\u00e9carie-Spain L., Fioramonti X., Guiard B., Nakajima S. (2022). The menace of obesity to depression and anxiety prevalence. Trends Endocrinol. Metab. 33 (1), 18\u201335. 10.1016/j.tem.2021.10.005", "ArticleIdList": ["10.1016/j.tem.2021.10.005", "34750064"]}, {"Citation": "Gandhi P. M., Chabukswar A. R., Jagdale S. C. (2019). Carriers for prodrug synthesis: A review. Indian J. Pharm. Sci. 81 (3), 406\u2013414. 10.36468/pharmaceutical-sciences.524", "ArticleIdList": ["10.36468/pharmaceutical-sciences.524"]}, {"Citation": "Ghasemi A., Jeddi S. (2017). Anti-obesity and anti-diabetic effects of nitrate and nitrite. Nitric Oxide 70 (1), 9\u201324. 10.1016/j.niox.2017.08.003", "ArticleIdList": ["10.1016/j.niox.2017.08.003", "28804022"]}, {"Citation": "Habtemariam S. (2020). The quest to enhance the efficacy of berberine for type-2 diabetes and associated diseases: Physicochemical modification approaches. Biomedicines 8 (4), 90. 10.3390/biomedicines8040090", "ArticleIdList": ["10.3390/biomedicines8040090", "PMC7235753", "32325761"]}, {"Citation": "Han J., Lin H., Huang W. (2011). Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med. Sci. Monit. 17 (7), RA164\u20137. 10.12659/msm.881842", "ArticleIdList": ["10.12659/msm.881842", "PMC3539561", "21709646"]}, {"Citation": "Heck A. M., Yanovski J. A., Calis K. A. (2000). Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20 (3), 270\u2013279. 10.1592/phco.20.4.270.34882", "ArticleIdList": ["10.1592/phco.20.4.270.34882", "PMC6145169", "10730683"]}, {"Citation": "\nHiggins O., Rule S., Cleary J. (2021). Analgesics of the future: The potential of vocacapsaicin injections for knee pain. Pract. Pain Manag.\n21 (2). https://www.practicalpainmanagement.com/\n"}, {"Citation": "Hu Y., Davies G. E. (2009). Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine 16 (9), 864\u2013873. 10.1016/j.phymed.2009.03.002", "ArticleIdList": ["10.1016/j.phymed.2009.03.002", "19403287"]}, {"Citation": "Hu Y., Davies G. E. (2010). Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia 81 (5), 358\u2013366. 10.1016/j.fitote.2009.10.010", "ArticleIdList": ["10.1016/j.fitote.2009.10.010", "19861153"]}, {"Citation": "Ireson C. R., Jones D. J., Orr S., Coughtrie M. W., Boocock D. J., Williams M. L., et al. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11 (1), 105\u2013111.", "ArticleIdList": ["11815407"]}, {"Citation": "Jayarathne S., Koboziev I., Park O. H., Oldewage-Theron W., Shen C. L., Moustaid-Moussa N. (2017). Anti-inflammatory and anti-obesity properties of food bioactive components: Effects on adipose tissue. Prev. Nutr. Food Sci. 22 (4), 251\u2013262. 10.3746/pnf.2017.22.4.251", "ArticleIdList": ["10.3746/pnf.2017.22.4.251", "PMC5758087", "29333376"]}, {"Citation": "Jeon H., Huynh D. T. N., Baek N., Nguyen T. L. L., Heo K. S. (2021). Ginsenoside-Rg2 affects cell growth via regulating ROS-mediated AMPK activation and cell cycle in MCF-7 cells. Phytomedicine. 85, 153549. 10.1016/j.phymed.2021.153549", "ArticleIdList": ["10.1016/j.phymed.2021.153549", "33819767"]}, {"Citation": "Jiang Y. Y., Shui J. C., Zhang B. X., Chin J. W., Yue R. S. (2020). The potential roles of artemisinin and its derivatives in the treatment of type 2 diabetes mellitus. Front. Pharmacol. 11, 585487. 10.3389/fphar.2020.585487", "ArticleIdList": ["10.3389/fphar.2020.585487", "PMC7768903", "33381036"]}, {"Citation": "Khadka S., Omura S., Sato F., Nishio K., Kakeya H., Tsunoda I. (2021). Curcumin \u03b2-D-glucuronide modulates an autoimmune model of multiple sclerosis with altered gut microbiota in the ileum and feces. Front. Cell. Infect. Microbiol. 11, 772962. 10.3389/fcimb.2021.772962", "ArticleIdList": ["10.3389/fcimb.2021.772962", "PMC8677657", "34926318"]}, {"Citation": "Kim H., Lee J. H., Kim J. E., Kim Y. S., Ryu C. H., Lee H. J., et al. (2018). Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability. J. Ginseng Res. 42 (3), 361\u2013369. 10.1016/j.jgr.2017.12.003", "ArticleIdList": ["10.1016/j.jgr.2017.12.003", "PMC6026383", "29983618"]}, {"Citation": "Knotts T., Mease K., Sangameswaran L., Felx M., Kramer S., Donovan J. (2022). Pharmacokinetics and local tissue response to local instillation of vocacapsaicin, a novel capsaicin prodrug, in rat and rabbit osteotomy models. J. Orthop. Res., 6. 10.1002/jor.25271", "ArticleIdList": ["10.1002/jor.25271", "35128722"]}, {"Citation": "Koboziev I., Scoggin S., Gong X., Mirzaei P., Zabet-Moghaddam M., Yosofvand M., et al. (2020). Effects of curcumin in a mouse model of very high fat diet-induced obesity. Biomolecules 10 (10), 1368. 10.3390/biom10101368", "ArticleIdList": ["10.3390/biom10101368", "PMC7650718", "32992936"]}, {"Citation": "Kokil G. R., Rewatkar P. V. (2010). Bioprecursor prodrugs: Molecular modification of the active principle. Mini Rev. Med. Chem. 10, 1316\u20131330. 10.2174/138955710793564179", "ArticleIdList": ["10.2174/138955710793564179", "20937026"]}, {"Citation": "Lang T., Li N., Zhang J., Li Y., Rong R., Fu Y. (2021). Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro . Drug Deliv. 28 (1), 1272\u20131280. 10.1080/10717544.2021.1938754", "ArticleIdList": ["10.1080/10717544.2021.1938754", "PMC8238065", "34176381"]}, {"Citation": "Law S., Au D. C., Leung A. W., Xu C. (2022). Curcumin\u201d for body\u2019s immunity. Int. Jr. Infect Dis Epidemlgy. 3 (2), 50\u201351. 10.51626/ijide.2022.03.00020", "ArticleIdList": ["10.51626/ijide.2022.03.00020"]}, {"Citation": "Law S., Leung A. W., Xu C. (2020). Is the traditional Chinese herb \"Artemisia annua\" possible to fight against COVID-19? Integr. Med. Res. 9 (3), 100474. 10.1016/j.imr.2020.100474", "ArticleIdList": ["10.1016/j.imr.2020.100474", "PMC7362865", "32742919"]}, {"Citation": "Li H., Jiang H., Xu L., Deng Y., Xu J., Zhao Y. (2022). Effects of different extraction methods in pharmacopoeia on the content and structure transformation of ginsenosides. Molecules 27 (14), 4347. 10.3390/molecules27144347", "ArticleIdList": ["10.3390/molecules27144347", "PMC9351678", "35889220"]}, {"Citation": "Li W. F., Jiang J. G., Chen J. (2008). Chinese medicine and its modernization demands. Arch. Med. Res. 39 (2), 246\u2013251. 10.1016/j.arcmed.2007.09.011", "ArticleIdList": ["10.1016/j.arcmed.2007.09.011", "18164973"]}, {"Citation": "Li X., Liu Z. (2021). Triptolide exhibits anti-inflammatory effects on adipocytes and macrophages by inhibition of AMPK/mTOR pathway. North Carolina: Researchsquare. 10.21203/rs.3.rs-944266/v1", "ArticleIdList": ["10.21203/rs.3.rs-944266/v1"]}, {"Citation": "Li Y., Cao H., Liu M., Zhang B., Zhang X., Shi D., et al. (2018). Different modulation of Panax notoginseng on the absorption profiling of triptolide and tripterine from Tripterygium wilfordii in rat intestine. Chin. Med. 13, 1. 10.1186/s13020-017-0157-6", "ArticleIdList": ["10.1186/s13020-017-0157-6", "PMC5759299", "29321807"]}, {"Citation": "Li Y., Ren G., Wang Y. X., Kong W. J., Yang P., Wang Y. M., et al. (2011). Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J. Transl. Med. 15 (9), 62. 10.1186/1479-5876-9-62", "ArticleIdList": ["10.1186/1479-5876-9-62", "PMC3103436", "21569619"]}, {"Citation": "Liu H., Yang J., Du F., Gao X., Ma X., Huang Y., et al. (2009). Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos. 37 (12), 2290\u20132298. 10.1124/dmd.109.029819", "ArticleIdList": ["10.1124/dmd.109.029819", "19786509"]}, {"Citation": "Liu J., Lee J., Salazar Hernandez M. A., Mazitschek R., Ozcan U. (2015). Treatment of obesity with celastrol. Cell 161 (5), 999\u20131011. 10.1016/j.cell.2015.05.011", "ArticleIdList": ["10.1016/j.cell.2015.05.011", "PMC4768733", "26000480"]}, {"Citation": "Liu R., Zhang J., Liu W., Kimura Y., Zheng Y. (2010). Anti-Obesity effects of protopanaxdiol types of Ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet. Fitoterapia 81 (8), 1079\u20131087. 10.1016/j.fitote.2010.07.002", "ArticleIdList": ["10.1016/j.fitote.2010.07.002", "20627120"]}, {"Citation": "Liu X., Zhi X., Liu Y., Wu B., Sun Z., Shen J. (2012). Effect of chitosan, O-carboxymethyl chitosan, and N-[(2-hydroxy-3-N, N-dimethylhexadecyl ammonium)propyl] chitosan chloride on overweight and insulin resistance in a murine diet-induced obesity. J. Agric. Food Chem. 60 (13), 3471\u20133476. 10.1021/jf205226r", "ArticleIdList": ["10.1021/jf205226r", "22400987"]}, {"Citation": "Loos R. J. F., Yeo G. S. H. (2022). The genetics of obesity: From discovery to biology. Nat. Rev. Genet. 23, 120\u2013133. 10.1038/s41576-021-00414-z", "ArticleIdList": ["10.1038/s41576-021-00414-z", "PMC8459824", "34556834"]}, {"Citation": "Lu M., Cao Y., Ho C. T., Huang Q. (2017). The enhanced anti-obesity effect and reduced gastric mucosa irritation of capsaicin-loaded nanoemulsions. Food Funct. 8 (5), 1803\u20131809. 10.1039/c7fo00173h", "ArticleIdList": ["10.1039/c7fo00173h", "28443906"]}, {"Citation": "Lu P., Zhang F. C., Qian S. W., Li X., Cui Z. M., Dang Y. J., et al. (2016). Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function. Cell Res. 26 (10), 1169\u20131172. 10.1038/cr.2016.108", "ArticleIdList": ["10.1038/cr.2016.108", "PMC5113303", "27633061"]}, {"Citation": "Luo C., Sun J., Sun B., He Z. (2014). Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol. Sci. 35 (11), 556\u2013566. 10.1016/j.tips.2014.09.008", "ArticleIdList": ["10.1016/j.tips.2014.09.008", "25441774"]}, {"Citation": "Lv J., Zhuang W., Zhang Y., Xie L., Xiang Z., Zhao Q., et al. (2021). 9, 10-anhydrodehydroartemisinin attenuates experimental autoimmune encephalomyelitis by inhibiting Th1 and Th17 cell differentiation. Inflammation 44 (5), 1793\u20131802. 10.1007/s10753-021-01456-5", "ArticleIdList": ["10.1007/s10753-021-01456-5", "33788130"]}, {"Citation": "Mahalak K. K., Bobokalonov J., Firrman J., Williams R., Evans B., Fanelli B., et al. (2022). Analysis of the ability of capsaicin to modulate the human gut microbiota in vitro . Nutrients 14 (6), 1283. 10.3390/nu14061283", "ArticleIdList": ["10.3390/nu14061283", "PMC8950947", "35334939"]}, {"Citation": "Marics B., Peitl B., P\u00e1zm\u00e1ndi K., B\u00e1csi A., N\u00e9meth J., Oszl\u00e1cs O., et al. (2017). Diet-induced obesity enhances TRPV1-mediated neurovascular reactions in the dura mater. Headache 57 (3), 441\u2013454. 10.1111/head.13033", "ArticleIdList": ["10.1111/head.13033", "28133727"]}, {"Citation": "Markovic M., Ben-Shabat S., Dahan A. (2020). Prodrugs for improved drug delivery: Lessons learned from recently developed and marketed products. Pharmaceutics 12 (11), 1031. 10.3390/pharmaceutics12111031", "ArticleIdList": ["10.3390/pharmaceutics12111031", "PMC7692606", "33137942"]}, {"Citation": "Mattarei A., Azzolini M., La Spina M., Zoratti M., Paradisi C., Biasutto L. (2015). Amino acid carbamates as prodrugs of resveratrol. Sci. Rep. 5, 15216. 10.1038/srep15216", "ArticleIdList": ["10.1038/srep15216", "PMC4604475", "26463125"]}, {"Citation": "Muangnoi C., Ratnatilaka N. B. P., Jithavech P., Supasena W., Paraoan L., Patumraj S., et al. (2019). Curcumin diethyl disuccinate, a prodrug of curcumin, enhances anti-proliferative effect of curcumin against HepG2 cells via apoptosis induction. Sci. Rep. 9, 11718. 10.1038/s41598-019-48124-1", "ArticleIdList": ["10.1038/s41598-019-48124-1", "PMC6690956", "31406217"]}, {"Citation": "Nurcahyanti A. D. R., Cokro F., Wulanjati M. P., Mahmoud M. F., Wink M., Sobeh M. (2022). Curcuminoids for metabolic syndrome: Meta-analysis evidences toward personalized prevention and treatment management. Front. Nutr. 9, 891339. 10.3389/fnut.2022.891339", "ArticleIdList": ["10.3389/fnut.2022.891339", "PMC9218575", "35757255"]}, {"Citation": "Och A., Podg\u00f3rski R., Nowak R. (2020). Biological activity of berberine-A summary update. Toxins (Basel) 12 (11), 713. 10.3390/toxins12110713", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Pan X. F., Wang L., Pan A. (2021). Epidemiology and determinants of obesity in China. Lancet. Diabetes Endocrinol. 9 (6), 373\u2013392. Erratum in: Lancet Diabetes Endocrinol. (2021) 9(7):e2. 10.1016/S2213-8587(21)00045-0", "ArticleIdList": ["10.1016/S2213-8587(21)00045-0", "34022156"]}, {"Citation": "Patil S., Lis L. G., Schumacher R. J., Norris B. J., Morgan M. L., Cuellar R. A., et al. (2015). Phosphonooxymethyl prodrug of triptolide: Synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts. J. Med. Chem. 58 (23), 9334\u20139344. 10.1021/acs.jmedchem.5b01329", "ArticleIdList": ["10.1021/acs.jmedchem.5b01329", "PMC4678411", "26596892"]}, {"Citation": "Perez C., Daniel K. B., Cohen S. M. (2013). Evaluating prodrug strategies for esterase-triggered release of alcohols. ChemMedChem 8 (10), 1662\u20131667. 10.1002/cmdc.201300255", "ArticleIdList": ["10.1002/cmdc.201300255", "PMC3918245", "23929690"]}, {"Citation": "Phumsuay R., Muangnoi C., Dasuni Wasana P. W., Hasriadi Vajragupta O., Rojsitthisak P., et al. (2020). Molecular insight into the anti-inflammatory effects of the curcumin ester prodrug curcumin diglutaric acid in vitro and in vivo . Int. J. Mol. Sci. 21 (16), 5700. 10.3390/ijms21165700", "ArticleIdList": ["10.3390/ijms21165700", "PMC7461142", "32784830"]}, {"Citation": "Raimund M., Kubinyi H., Folkers G. (2011). Prodrugs and targeted delivery: Towards better ADME properties. John Wiley Sons 1 (47), 131\u2013151. 10.1002/9783527633166.ch1", "ArticleIdList": ["10.1002/9783527633166.ch1"]}, {"Citation": "Robertson C. L., Srivastava J., Siddiq A., Gredler R., Emdad L., Rajasekaran D., et al. (2015). Astrocyte elevated gene-1 (AEG-1) regulates lipid homeostasis. J. Biol. Chem. 290 (29), 18227\u201318236. 10.1074/jbc.M115.661801", "ArticleIdList": ["10.1074/jbc.M115.661801", "PMC4505065", "26070567"]}, {"Citation": "Rogero M. M., Calder P. C. (2018). Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients 10 (4), 432. 10.3390/nu10040432", "ArticleIdList": ["10.3390/nu10040432", "PMC5946217", "29601492"]}, {"Citation": "Shah K., Gupta J. K., Chauhan N. S., Upmanyu N., Shrivastava S. K., Mishra P. (2017). Prodrugs of NSAIDs: A review. Open Med. Chem. J. 11, 146\u2013195. 10.2174/1874104501711010146", "ArticleIdList": ["10.2174/1874104501711010146", "PMC5748882", "29387273"]}, {"Citation": "Shen S., Liao Q., Lyu M., Wong Y. K., Zhang X., Zhou J., et al. (2020). The potential of artemisinins as anti-obesity agents via modulating the immune system. Pharmacol. Ther. 216, 107696. 10.1016/j.pharmthera.2020.107696", "ArticleIdList": ["10.1016/j.pharmthera.2020.107696", "33022301"]}, {"Citation": "Shi Z. Y., Zeng J. Z., Wong A. S. T. (2019). Chemical structures and pharmacological profiles of ginseng saponins. Molecules 24 (13), 2443. 10.3390/molecules24132443", "ArticleIdList": ["10.3390/molecules24132443", "PMC6651355", "31277214"]}, {"Citation": "Shitan N., Bazin I., Dan K., Obata K., Kigawa K., Ueda K., et al. (2003). Involvement of CjMDR1, a plant multidrug-resistance-type ATP-binding cassette protein, in alkaloid transport in Coptis japonica. Proc. Natl. Acad. Sci. U. S. A. 100 (2), 751\u2013756. 10.1073/pnas.0134257100", "ArticleIdList": ["10.1073/pnas.0134257100", "PMC141068", "12524452"]}, {"Citation": "Soleimani V., Sahebkar A., Hosseinzadeh H. (2018). Turmeric (curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother. Res. 32, 985\u2013995. 10.1002/PTR.6054", "ArticleIdList": ["10.1002/PTR.6054", "29480523"]}, {"Citation": "Straub R. H. (2017). The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nat. Rev. Rheumatol. 13, 743\u2013751. 10.1038/nrrheum.2017.172", "ArticleIdList": ["10.1038/nrrheum.2017.172", "29021568"]}, {"Citation": "Sugiarto S. R., Page-Sharp M., Drinkwater J. J., Davis W. A., Salman S., Davis T. M. E. (2022). Pharmacokinetic properties of the antimalarial combination therapy artemether-lumefantrine in normal-weight, overweight and obese healthy male adults. Int. J. Antimicrob. Agents 59 (1), 106482. 10.1016/j.ijantimicag.2021.106482", "ArticleIdList": ["10.1016/j.ijantimicag.2021.106482", "34818520"]}, {"Citation": "Sui Y., Zhao H. L., Wong V. C., Brown N., Li X. L., Kwan A. K., et al. (2012). A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obes. Rev. 13 (5), 409\u2013430. 10.1111/j.1467-789X.2011.00979.x", "ArticleIdList": ["10.1111/j.1467-789X.2011.00979.x", "22292480"]}, {"Citation": "Tak Y. J., Lee S. Y. (2021). Long-term efficacy and safety of anti-obesity treatment: Where do we stand? Curr. Obes. Rep. 10, 14\u201330. 10.1007/s13679-020-00422-w", "ArticleIdList": ["10.1007/s13679-020-00422-w", "PMC7787121", "33410104"]}, {"Citation": "Testa B. (2009). Prodrugs: Bridging pharmacodynamic/pharmacokinetic gaps. Curr. Opin. Chem. Biol. 3, 338\u2013344. 10.1016/j.cbpa.2009.04.620", "ArticleIdList": ["10.1016/j.cbpa.2009.04.620", "19473869"]}, {"Citation": "Tsai Y. Z., Tsai M. L., Hsu L. Y., Ho C. T., Lai C. S. (2021). Tetrahydrocurcumin upregulates the adiponectin-AdipoR pathway and improves insulin signaling and pancreatic \u03b2-cell function in high-fat diet/streptozotocin-induced diabetic obese mice. Nutrients 13 (12), 4552. 10.3390/nu13124552", "ArticleIdList": ["10.3390/nu13124552", "PMC8707974", "34960104"]}, {"Citation": "Venkatesha S. H., Moudgil K. D. (2016). Celastrol and its role in controlling chronic diseases. Adv. Exp. Med. Biol. 928, 267\u2013289. 10.1007/978-3-319-41334-1_12", "ArticleIdList": ["10.1007/978-3-319-41334-1_12", "PMC8056454", "27671821"]}, {"Citation": "Wang L., Zhang B., Huang F., Liu B., Xie Y. (2016). Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance. J. Lipid Res. 57, 1243\u20131255. 10.1194/JLR.M067397", "ArticleIdList": ["10.1194/JLR.M067397", "PMC4918853", "27220352"]}, {"Citation": "Wang Y., Tang C., Tang Y., Yin H., Liu X. (2020). Capsaicin has an anti-obesity effect through alterations in gut microbiota populations and short-chain fatty acid concentrations. Food Nutr. Res. 19, 64. 10.29219/fnr.v64.3525", "ArticleIdList": ["10.29219/fnr.v64.3525", "PMC7054644", "32180694"]}, {"Citation": "Wermuth C. G. (2008). The practice of medicinal chemistry. Amsterdam: Elsevier, 721\u2013746."}, {"Citation": "Wink M. (2022). Current understanding of modes of action of multicomponent bioactive phytochemicals: Potential for nutraceuticals and antimicrobials. Annu. Rev. Food Sci. Technol. 13, 337\u2013359. 10.1146/annurev-food-052720-100326", "ArticleIdList": ["10.1146/annurev-food-052720-100326", "35333591"]}, {"Citation": "Wink M. (2015). Modes of action of herbal medicines and plant secondary metabolites. Medicines 2, 251\u2013286. 10.3390/MEDICINES2030251", "ArticleIdList": ["10.3390/MEDICINES2030251", "PMC5456217", "28930211"]}, {"Citation": "Yan R., Yang Y., Chen Y. (2018). Pharmacokinetics of Chinese medicines: Strategies and perspectives. Chin. Med. 13, 24. 10.1186/s13020-018-0183-z", "ArticleIdList": ["10.1186/s13020-018-0183-z", "PMC5930430", "29743935"]}, {"Citation": "Yang Z., Gao S., Wang J., Yin T., Teng Y., Wu B., et al. (2011). Enhancement of oral bioavailability of 20(S)-Ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab. Dispos. 39 (10), 1866\u20131872. 10.1124/dmd.111.040006", "ArticleIdList": ["10.1124/dmd.111.040006", "21757611"]}, {"Citation": "Ye M., Qiu H., Cao Y., Zhang M., Mi Y., Yu J., et al. (2017). Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum. Front. Pharmacol. 8, 148. 10.3389/fphar.2017.00148", "ArticleIdList": ["10.3389/fphar.2017.00148", "PMC5359258", "28377722"]}, {"Citation": "Yoo S., Park B. I., Kim D. H., Lee S., Lee S. H., Shim W. S., et al. (2021). Ginsenoside absorption rate and extent enhancement of black ginseng (CJ EnerG) over red ginseng in healthy adults. Pharmaceutics 13 (4), 487. 10.3390/pharmaceutics13040487", "ArticleIdList": ["10.3390/pharmaceutics13040487", "PMC8067055", "33918329"]}, {"Citation": "Yu Q., Liu Y., Wu Y., Chen Y. (2018). Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells. Biomed. Pharmacother. 103, 1327\u20131336. 10.1016/j.biopha.2018.04.143", "ArticleIdList": ["10.1016/j.biopha.2018.04.143", "29864915"]}, {"Citation": "Zawilska J. B., Wojcieszak J., Olejniczak A. B. (2013). Prodrugs: A challenge for the drug development. Pharmacol. Rep. 65, 1\u201314. 10.1016/s1734-1140(13)70959-9", "ArticleIdList": ["10.1016/s1734-1140(13)70959-9", "23563019"]}, {"Citation": "Zhang Y., Cui H., Zhang R., Zhang H., Huang W. (2021). Nanoparticulation of prodrug into medicines for cancer therapy. Adv. Sci. 8 (18), e2101454. 10.1002/advs.202101454", "ArticleIdList": ["10.1002/advs.202101454", "PMC8456229", "34323373"]}, {"Citation": "Zhang Y., Lv J., Zhang S., Yang H., Shen J., Du C., et al. (2022). Synthesis and biological evaluation of artemisinin derivatives as potential MS agents. Bioorg. Med. Chem. Lett. 64, 128682. 10.1016/j.bmcl.2022.128682", "ArticleIdList": ["10.1016/j.bmcl.2022.128682", "35304225"]}, {"Citation": "Zhang Y., Pei Q., Yue Y., Xie Z. (2022). Binary dimeric prodrug nanoparticles for self-boosted drug release and synergistic chemo-photodynamic therapy. J. Mat. Chem. B 10 (6), 880\u2013886. 10.1039/d1tb02638k", "ArticleIdList": ["10.1039/d1tb02638k", "35043826"]}, {"Citation": "Zou T., Li S., Wang B., Wang Z., Liu Y., You J. (2021). Curcumin improves insulin sensitivity and increases energy expenditure in high-fat-diet-induced obese mice associated with activation of FNDC5/irisin. Nutrition 90, 111263. 10.1016/j.nut.2021.111263", "ArticleIdList": ["10.1016/j.nut.2021.111263", "33975064"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "10"}, {"Year": "2022", "Month": "9", "Day": "14"}, {"Year": "2022", "Month": "10", "Day": "20", "Hour": "2", "Minute": "56"}, {"Year": "2022", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["36263142", "PMC9573959", "10.3389/fphar.2022.1016004", "1016004"]}}], "PubmedBookArticle": []}